Biblio

Export 2654 results:
Author [ Title(Desc)] Type Year
Filters: First Letter Of Last Name is S  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
M. Vandermeeren, Borgers, M., Van Kolen, K., Theunis, C., Vasconcelos, B., Bottelbergs, A., Wintmolders, C., Daneels, G., Willems, R., Dockx, K., Delbroek, L., Marreiro, A., Donck, L. Ver, Sousa, C., Nanjunda, R., Lacy, E., Van De Casteele, T., Van Dam, D., De Deyn, P. Paul, Kemp, J. A., Malia, T. J., and Mercken, M. H., “Anti-Tau Monoclonal Antibodies Derived from Soluble and Filamentous Tau Show Diverse Functional Properties in vitro and in vivo.”, J Alzheimers Dis, vol. 65, no. 1, pp. 265-281, 2018.
C. Cui, Sekikawa, A., Kuller, L. H., Lopez, O. L., Newman, A. B., Kuipers, A. L., and Mackey, R. H., “Aortic Stiffness is Associated with Increased Risk of Incident Dementia in Older Adults.”, J Alzheimers Dis, vol. 66, no. 1, pp. 297-306, 2018.
H. Salem, Suchting, R., Gonzales, M. M., Seshadri, S., and Teixeira, A. L., “Apathy as a Predictor of Conversion from Mild Cognitive Impairment to Alzheimer's Disease: A Texas Alzheimer's Research and Care Consortium (TARCC) Cohort-Based Analysis.”, J Alzheimers Dis, vol. 92, no. 1, pp. 129-139, 2023.
H. Salem, Suchting, R., Gonzales, M. M., Seshadri, S., and Teixeira, A. L., “Apathy as a Predictor of Conversion from Mild Cognitive Impairment to Alzheimer's Disease: A Texas Alzheimer's Research and Care Consortium (TARCC) Cohort-Based Analysis.”, J Alzheimers Dis, vol. 92, no. 1, pp. 129-139, 2023.
H. Salem, Suchting, R., Gonzales, M. M., Seshadri, S., and Teixeira, A. L., “Apathy as a Predictor of Conversion from Mild Cognitive Impairment to Alzheimer's Disease: A Texas Alzheimer's Research and Care Consortium (TARCC) Cohort-Based Analysis.”, J Alzheimers Dis, vol. 92, no. 1, pp. 129-139, 2023.
J. B. Toledo, Habes, M., Sotiras, A., Bjerke, M., Fan, Y., Weiner, M. W., Shaw, L. M., Davatzikos, C., and Trojanowski, J. Q., “APOE Effect on Amyloid-β PET Spatial Distribution, Deposition Rate, and Cut-Points.”, J Alzheimers Dis, vol. 69, no. 3, pp. 783-793, 2019.
J. B. Toledo, Habes, M., Sotiras, A., Bjerke, M., Fan, Y., Weiner, M. W., Shaw, L. M., Davatzikos, C., and Trojanowski, J. Q., “APOE Effect on Amyloid-β PET Spatial Distribution, Deposition Rate, and Cut-Points.”, J Alzheimers Dis, vol. 69, no. 3, pp. 783-793, 2019.
M. Berger, Cooter, M., Roesler, A. S., Chung, S., Park, J., Modliszewski, J. L., VanDusen, K. W., J Thompson, W., Moseley, A., Devinney, M. J., Smani, S., Hall, A., Cai, V., Browndyke, J. N., Lutz, M. W., and Corcoran, D. L., “APOE4 Copy Number-Dependent Proteomic Changes in the Cerebrospinal Fluid.”, J Alzheimers Dis, vol. 79, no. 2, pp. 511-530, 2021.
S. Hollands, Lim, Y. Ying, Laws, S. M., Villemagne, V. L., Pietrzak, R. H., Harrington, K., Porter, T., Snyder, P., Ames, D., Fowler, C., Rainey-Smith, S. R., Martins, R. N., Salvado, O., Robertson, J., Rowe, C. C., Masters, C. L., and Maruff, P., “APOEɛ4 Genotype, Amyloid, and Clinical Disease Progression in Cognitively Normal Older Adults.”, J Alzheimers Dis, vol. 57, no. 2, 2017.
S. Hollands, Lim, Y. Ying, Laws, S. M., Villemagne, V. L., Pietrzak, R. H., Harrington, K., Porter, T., Snyder, P., Ames, D., Fowler, C., Rainey-Smith, S. R., Martins, R. N., Salvado, O., Robertson, J., Rowe, C. C., Masters, C. L., and Maruff, P., “APOEɛ4 Genotype, Amyloid, and Clinical Disease Progression in Cognitively Normal Older Adults.”, J Alzheimers Dis, vol. 57, no. 2, 2017.
R. Cardoso, Lemos, C., Oliveiros, B., Almeida, M. Rosário, Baldeiras, I., Pereira, C. Fragão, Santos, A., Duro, D., Vieira, D., Santana, I., and Oliveira, C. Resende, “APOEɛ4-TOMM40L Haplotype Increases the Risk of Mild Cognitive Impairment Conversion to Alzheimer's Disease.”, J Alzheimers Dis, vol. 78, no. 2, pp. 587-601, 2020.
R. Cardoso, Lemos, C., Oliveiros, B., Almeida, M. Rosário, Baldeiras, I., Pereira, C. Fragão, Santos, A., Duro, D., Vieira, D., Santana, I., and Oliveira, C. Resende, “APOEɛ4-TOMM40L Haplotype Increases the Risk of Mild Cognitive Impairment Conversion to Alzheimer's Disease.”, J Alzheimers Dis, vol. 78, no. 2, pp. 587-601, 2020.
R. E. R. Slot, Van Harten, A. C., Kester, M. I., Jongbloed, W., Bouwman, F. H., Teunissen, C. E., Scheltens, P., Veerhuis, R., and van der Flier, W. M., “Apolipoprotein A1 in Cerebrospinal Fluid and Plasma and Progression to Alzheimer's Disease in Non-Demented Elderly.”, J Alzheimers Dis, vol. 56, no. 2, pp. 687-697, 2017.
R. E. R. Slot, Van Harten, A. C., Kester, M. I., Jongbloed, W., Bouwman, F. H., Teunissen, C. E., Scheltens, P., Veerhuis, R., and van der Flier, W. M., “Apolipoprotein A1 in Cerebrospinal Fluid and Plasma and Progression to Alzheimer's Disease in Non-Demented Elderly.”, J Alzheimers Dis, vol. 56, no. 2, pp. 687-697, 2017.
E. Dorey, Bamji-Mirza, M., Najem, D., Li, Y., Liu, H., Callaghan, D., Walker, D., Lue, L. - F., Stanimirovic, D., and Zhang, W., “Apolipoprotein E Isoforms Differentially Regulate Alzheimer's Disease and Amyloid-β-Induced Inflammatory Response in vivo and in vitro.”, J Alzheimers Dis, vol. 57, no. 4, pp. 1265-1279, 2017.
S. K. Singhrao, Harding, A., Chukkapalli, S., Olsen, I., Kesavalu, L., and Crean, S. J., “Apolipoprotein E Related Co-Morbidities and Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 4, pp. 935-48, 2016.
M. Basta, Zaganas, I., Simos, P., Koutentaki, E., Dimovasili, C., Mathioudakis, L., Bourbouli, M., Panagiotakis, S., Kapetanaki, S., and Vgontzas, A., “Apolipoprotein E ɛ4 (APOE ɛ4) Allele is Associated with Long Sleep Duration Among Elderly with Cognitive Impairment.”, J Alzheimers Dis, vol. 79, no. 2, pp. 763-771, 2021.
T. Persson, Lattanzio, F., Calvo-Garrido, J., Rimondini, R., Rubio-Rodrigo, M., Sundström, E., Maioli, S., Sandebring-Matton, A., and Cedazo-Minguez, A., “Apolipoprotein E4 Elicits Lysosomal Cathepsin D Release, Decreased Thioredoxin-1 Levels, and Apoptosis.”, J Alzheimers Dis, vol. 56, no. 2, pp. 601-617, 2017.
T. Persson, Lattanzio, F., Calvo-Garrido, J., Rimondini, R., Rubio-Rodrigo, M., Sundström, E., Maioli, S., Sandebring-Matton, A., and Cedazo-Minguez, A., “Apolipoprotein E4 Elicits Lysosomal Cathepsin D Release, Decreased Thioredoxin-1 Levels, and Apoptosis.”, J Alzheimers Dis, vol. 56, no. 2, pp. 601-617, 2017.
C. J. Smith and J Ashford, W., “Apolipoprotein ɛ4-Associated Protection Against Pediatric Enteric Infections is a Survival Advantage in Pre-Industrial Populations.”, J Alzheimers Dis, vol. 93, no. 3, pp. 907-918, 2023.
N. Nakamura, Ohyagi, Y., Imamura, T., Yanagihara, Y. T., Iinuma, K. M., Soejima, N., Murai, H., Yamasaki, R., and Kira, J. - I., “Apomorphine Therapy for Neuronal Insulin Resistance in a Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1151-1161, 2017.
F. Sellal, Wallon, D., Martinez-Almoyna, L., Marelli, C., Dhar, A., Oesterlé, H., Rovelet-Lecrux, A., Rousseau, S., Kourkoulis, C. E., Rosand, J., DiPucchio, Z. Y., Frosch, M., Gombert, C., Audoin, B., Miné, M., Riant, F., Frebourg, T., Hannequin, D., Campion, D., Greenberg, S. M., Tournier-Lasserve, E., and Nicolas, G., “APP Mutations in Cerebral Amyloid Angiopathy with or without Cortical Calcifications: Report of Three Families and a Literature Review.”, J Alzheimers Dis, vol. 56, no. 1, pp. 37-46, 2017.
T. B. Shea and Remington, R., “Apparent Cognitive Decline as Revealed by an Executive Function Test within a Cohort of Elderly Individuals Self-Reporting Normal Cognitive Performance.”, J Alzheimers Dis, vol. 61, no. 3, pp. 913-915, 2018.
J. Yang, Zhang, R., Shi, C., Mao, C., Yang, Z., Suo, Z., Torp, R., and Xu, Y., “AQP4 Association with Amyloid Deposition and Astrocyte Pathology in the Tg-ArcSwe Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 57, no. 1, pp. 157-169, 2017.
J. Yang, Zhang, R., Shi, C., Mao, C., Yang, Z., Suo, Z., Torp, R., and Xu, Y., “AQP4 Association with Amyloid Deposition and Astrocyte Pathology in the Tg-ArcSwe Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 57, no. 1, pp. 157-169, 2017.

Pages